Kidney cancer

Linehan, 2003, The genetic basis of cancer of the kidney, J Urol, 170, 2163, 10.1097/01.ju.0000096060.92397.ed Linehan, 2010, The genetic basis of kidney cancer: a metabolic disease, Nat Rev Urol, 7, 277, 10.1038/nrurol.2010.47 Isaacs, 2005, HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability, Cancer Cell, 8, 143, 10.1016/j.ccr.2005.06.017 Tong, 2011, The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases metabolic propensities and lowers cellular iron levels, Cancer Cell, 20, 315, 10.1016/j.ccr.2011.07.018 Mullen, 2011, Reductive carboxylation supports growth in tumour cells with defective mitochondria, Nature. On Line, 10.1038/nature10642 Ricketts, 2008, Germline SDHB mutations and familial renal cell carcinoma, J Natl Cancer Inst, 100, 1260, 10.1093/jnci/djn254 Yang, 2010, UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: In vitro and in vivo model of an aberrant energy metabolic pathway in human cancer, Cancer Genet Cytogenet, 196, 45, 10.1016/j.cancergencyto.2009.08.018 Liu, 2009, Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer, Science, 323, 1218, 10.1126/science.1157669 Dalgliesh, 2010, Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes, Nature, 463, 360, 10.1038/nature08672 Varela, 2011, Stratton: the BT MR, Futreal PA, Nature, 469, 539, 10.1038/nature09639 Kenneth, 2009, SWI/SNF regulates the cellular response to hypoxia, J Biol Chem, 284, 4123, 10.1074/jbc.M808491200 van, 2011, Treatment of localised renal cell carcinoma, Eur Urol, 60, 662, 10.1016/j.eururo.2011.06.040 van, 2011, A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma, Eur Urol, 59, 543, 10.1016/j.eururo.2010.12.013 Yang, 2007, Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis, J Immunother, 30, 825, 10.1097/CJI.0b013e318156e47e Sznol, 2010, Safety and antitumor activity of biweekly MDX-1106 (anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies, J Clin Oncol, 28 Jonasch, 2010, Axitinib with or without dose titration as first-line therapy for metastatic renal cell carcinoma (mRCC), J Clin Oncol, 28 Motzer, 2011, A phase III, randomized, controlled study to compare tivozanib with sorafenib in patients (pts) with advanced renal cell carcinoma (RCC), J Clin Oncol, 29, 310, 10.1200/jco.2011.29.7_suppl.310 Rini, 2011, Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial, Lancet, 378, 1931, 10.1016/S0140-6736(11)61613-9 Nosov, 2011, Final analysis of the phase II randomized discontinuation trial (RDT) of tivozanib (AV-951) versus placebo in patients with renal cell carcinoma (RCC), J Clin Oncol, 29 Huang, 2010, Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma, Cancer Res, 70, 1063, 10.1158/0008-5472.CAN-09-3965 Herbst, 2009, Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors, J Clin Oncol, 27, 3557, 10.1200/JCO.2008.19.6683 Shen, 2011, Genetic and functional studies implicate HIF1a as a 14q kidney cancer suppressor gene, Cancer Res, 22335 Cho, 2010, The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma, Clin Cancer Res, 16, 3628, 10.1158/1078-0432.CCR-09-3022 Zimmer, 2008, Small-molecule inhibitors of HIF-2a translation link its 5'UTR iron-responsive element to oxygen sensing, Mol Cell, 32, 838, 10.1016/j.molcel.2008.12.004 Peruzzi, 2006, The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells, Proc Natl Acad Sci U S A, 103, 14531, 10.1073/pnas.0606850103